Suchergebnisse - "Sadun, Rebecca E"

PubPharm (69)

1

Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity

enthalten in: Clinical rheumatology | 2024

von Rogers, J. | Clowse, M. | Pisetsky, D. | +7

2

What the SARS-CoV-2 Pandemic Has Taught Us About Immunosuppression, Vaccinations, and Immune Dysregulation : The Rheumatology Experience

enthalten in: Current allergy and asthma reports | 2024

von Jiang, Y. | Sadun, R.

3

What the SARS-CoV-2 Pandemic Has Taught Us About Immunosuppression, Vaccinations, and Immune Dysregulation: The Rheumatology Experience

enthalten in: Current allergy and asthma reports | 2024

von Jiang, Y. | Sadun, R.

4

Transition to Adult Rheumatology Care : A Disease-Specific Guide

enthalten in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases | 2024

von Cintron, D. | Chang, J. | Sadun, R.

5

The Type 1 & 2 systemic lupus erythematosus model : Perspectives of people living with systemic lupus erythematosus

enthalten in: Lupus | 2024

von Eudy, A. | Clowse, M. | Corneli, A. | +9

6

Evaluation of Type 2 SLE symptoms in patients with a range of lupus nephritis activity

enthalten in: Clinical rheumatology | 2024

von Rogers, J. | Clowse, M. | Pisetsky, D. | +7

7

Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Wang, C. | Sadun, R. | Zhou, W. | +19

8

A qualitative study of facilitators of medication adherence in systemic lupus erythematosus : Perspectives from rheumatology providers/staff and patients

enthalten in: Lupus | 2024

von Herndon, S. | Corneli, A. | Dombeck, C. | +9

9

Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood‐Onset Proliferative Lupus Nephritis

enthalten in: Arthritis & Rheumatology | 2024

von Wang, C. | Sadun, R. | Zhou, W. | +18

10

Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model : a cross sectional study

enthalten in: Journal of patient-reported outcomes | 2023

von Sun, K. | Eudy, A. | Harris, N. | +6

1
2
3
4
5
6
7
Nächster »
[7]